Eyes on New Product Development
- 1 February 2023
- journal article
- editorial
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 39 (1), 1-2
- https://doi.org/10.1089/jop.2023.29100.gdn
Abstract
Journal of Ocular Pharmacology and TherapeuticsThis publication has 6 references indexed in Scilit:
- Incomplete Enrollment in Clinical TrialsNeurology, 2022
- Efficacy of Prednisolone for Bell Palsy in ChildrenNeurology, 2022
- Remember, do no harm?Science, 2022
- The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b StudyOphthalmic Surgery, Lasers and Imaging Retina, 2022
- Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot StudyTranslational Vision Science & Technology, 2022
- Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018JAMA Health Forum, 2021